Overview

The International Vaccine Institute accelerates the development of vaccines for poverty-associated infectious diseases that sicken or kill millions of people every year, primarily in low- and middle-income countries. Though they have limited commercial potential, these vaccines are vital to global health. We also address emerging diseases with epidemic or pandemic potential, developing novel vaccine technologies and strengthening pandemic preparedness and health security. Through training and the transfer of knowledge, technology, and resources, we work with countries to achieve vaccine security and protect their people.

Our Science, CARE, and EPIC units lead vaccine discovery, development, and delivery efforts—across the vaccine value chain.

IVI’s mission is to discover, develop, and deliver safe, effective, and affordable vaccines—empowering vaccine equity, impact, and sustainability globally

Discover

  • Studying disease threats in the field, including emerging and neglected diseases.
  • Improving existing vaccines and identifying new candidates for research and development in our lab.
  • Conducting preclinical research to ensure vaccines are ready for further testing.

Develop

  • Developing and optimizing critical assays.
  • Establishing vaccine development processes.
  • Refining vaccine production methods and running clinical trials to test safety and efficacy.
  • Facilitating technology transfers to vaccine manufacturers and advising on regulatory strategy.

Deliver

  • Conducting vaccine effectiveness trials to assess real-world performance.
  • Introducing new vaccines with vaccination campaigns, research, and data to ensure they reach the people who need them.
  • Conducting health economic studies and vaccine cost-effectiveness analyses.
  • Advocating for health policies and monitoring the long-term impact and success of vaccines.

Empower

  • Ensuring vaccines are relevant and accessible to the populations that need them.
  • Prioritizing vaccines with limited commercial gain but high global health impact.
  • Incorporating training, technology transfer, and capacity-building across projects to ensure sustainable progress.
  • Helping manufacturers and low- and middle-income countries build the skills and facilities needed to make vaccines locally.